Catherine Leblanc
35Patents
6h-index
90Co-inventors
68Inventor score
Filing activity: Feb 27, 2003 → Apr 27, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9266883B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 15 | Active |
| US8314112B2 | Pyrrolopyrimidines and pyrrolopyridines | Chemistry; Metallurgy | 12 | Active |
| US9533988B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 12 | Active |
| US7989458B2 | Pyrimidine derivatives as alk-5 inhibitors | Chemistry; Metallurgy | 11 | Active |
| US8367662B2 | Organic compounds | Human Necessities | 7 | Active |
| US7666878B2 | Pyrrolopyridine derivatives and their use as Crth2 antagonists | Human Necessities | 7 | Expired |
| US7687637B2 | 5-phenylthiazole derivatives and use as Pi3 kinase inhibitors | Chemistry; Metallurgy | 6 | Expired |
| US8754085B2 | Pyrido[2,3-b]pyrazine compounds useful as IP receptor agonist | Chemistry; Metallurgy | 6 | Active |
| US8343966B2 | Organic compounds | Chemistry; Metallurgy | 5 | Active |
| US9132127B2 | Substituted pyrido[2,3-B]pyrazines as IP receptor agonists | Chemistry; Metallurgy | 4 | Active |
| US10130629B2 | Pharmaceutical combinations | Human Necessities | 3 | Active |
| US8455645B2 | Pyrrolopyridine derivatives and their use as CRTH2 antagonists | Human Necessities | 2 | Active |
| US9896449B2 | Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9802917B2 | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide | Chemistry; Metallurgy | 2 | Active |
| US8431578B2 | Organic compounds | Human Necessities | 2 | Active |
| US8470848B2 | Organic compounds | Human Necessities | 2 | Active |
| US8129541B2 | 5-phenylthiazole derivatives and use as PI3 kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7902375B2 | 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases | Chemistry; Metallurgy | 1 | Expired |
| US9174985B2 | Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists | Human Necessities | 1 | Active |
| US9079897B2 | Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors | Human Necessities | 1 | Active |
| US8431703B2 | Pyrrolopyridine compounds and their use in treating disease | Human Necessities | 1 | Active |
| US8937069B2 | Substituted pyrrolo[2,3-B]pyrazine compounds and their use | Human Necessities | 1 | Active |
| US8791256B2 | Pyrrolopyridine derivatives and their use as CRTH2 antagonists | Human Necessities | 0 | Active |
| US10189813B2 | Formylated N-heterocyclic derivatives as FGFR4 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11702409B2 | Pyrazolyl derivatives useful as anti-cancer agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.